{"nct_id":"NCT05194124","title":"Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2021-12-21","start_date_type":"ACTUAL","primary_completion_date":"2023-10-19","primary_completion_date_type":"ACTUAL","completion_date":"2023-10-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["RYTM"]}